@dansfera: The talk on the street is that the entire CRO outsourcing model is facing a massive reckoning. Squeezing margins is reportedly forcing a major shift where top pharma and even nimble biotechs are aggressively looking to pull scientific oversight and site relationships back in-house. If sponsors handle the core control, where does that leave the Contract Research Organizations? Time for CROs to figure out their real value-add, or risk being left behind in this industry shake-up! Pharma insiders are spilling the tea on this changing dynamic. 🤯 #CRO #PharmaNews #Biotech #Outsourcing #BusinessModel

120

There are no more comments for this video.

To see more videos from user @dansfera, please go to the Tikwm homepage.